Johnson & Johnson (JNJ)

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Pharmaceutical companies regularly encounter substantial headwinds. Among the most significant are patent cliffs -- when therapies lose patent exclusivity, inviting cheaper generic or biosimilar compe...

You can't time the market, but you can bank on a good dividend. Especially when stocks are swinging in volatile times, reliable income is a rare anchor.

Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock?

Both Amgen (AMGN) and Johnson & Johnson (JNJ) recently received a 60-day ultimatum to lower their prices in the U.S. market. A fundamental analysis shows AMGN to be better positioned than JNJ to absor...

Dollar General has issued a nationwide recall of its Clover Valley 8-ounce instant coffee after a customer reported finding glass fragments in the product, according to the FDA. Clover Valley is worki...

If you are in your 20's you likely have more than four decades ahead of you to invest before hitting retirement. Some might suggest that now is the time to take an aggressive investment stance, but th...

Johnson & Johnson's Q2 MedTech sales beat estimates, fueled by cardiovascular gains, surgical vision growth and new product momentum.

Right now is not a good time in the healthcare sector. Various companies across the space are well below highs while the broader stock market chugs along at all-time highs.

Long-term dividend plays tend to be more stable than many other stocks—after all, this stability is why they are able to provide consistent dividends in the first place. Traditional dividend stocks ar...